Anaptys surges as arthritis therapy succeeds in mid-stage trial Anaptys surges as arthritis therapy succeeds in mid-stage trial Post Contentanab, llyRead More You might also be interested in reading The Brink’s declares $0.2425 dividend. February 12, 2025 In Mainstream ← Previous post Next post →